BAYER PLC (WT) - WT2022-10 - AFLIBERCEPT (PFS) 3.6 mg in 90microlitres Intravitreal Injection;1 Pre-filled Syringe Pack - 3 YEARS

Official notice

Authority: Western Health & Social Care Trust (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£5,722,240published contract · exc. VAT

Awarded 26 Jan 2023no call for competition

Awarded to Bayer Plc

What is being bought

Published requirement description

Supply of AFLIBERCEPT (PFS) 3.6 mg in 90microlitres Intravitreal Injection;1 Pre-filled Syringe Pack to meet clinical need in the Western Trust for 3 YEARS

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 14 Feb 2023, 15:13 GMT
Last source update: 14 Feb 2023, 15:13 GMT
Authority reference: WT2022-10
FTS notice number: 2023/S 000-004537
Classification (CPV): Pharmaceutical products
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-03a597 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
The Western Health and Social Care Trust requires the purchase of AFLIBERCEPT (PFS) 3.6 mg in 90microlitres Intravitreal Injection;1 Pre-filled Syringe Pack (Eylea) which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative or substitute exists.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £5,722,2401 contract exc. VAT

Bids received 1

Contracts signed 1latest 26 Jan 2023

Awarded to	Value	Date	Status
Bayer Plc	£5,722,240 †	—	Awarded

Contracts

BAYER PLC (WT) - WT2022-10 - AFLIBERCEPT (PFS) 3.6 mg in 90microlitres Intravitreal Injection;1 Pre-filled Syringe Pack - 3 YEARS · Bayer Plc
Signed
26 Jan 2023
Value
£5,722,240
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

Western Health and Social Care Trust

Contracting authorityCentral GovernmentBody governed by public lawHealth Londonderry, Northern IrelandContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

BAYER PUBLIC LIMITED COMPANYAwarded supplierGB-COH: 00935048 400 South Oak Way, Reading, South East, RG2 6AD

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.